The latest market report published by Credence Research, Inc. “Global Oral Solid Dosage Contract Manufacturing Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. The global oral solid dosage contract manufacturing was valued at USD 32.5 Billion in 2022 and is expected to reach USD 49.8 Billion in 2030, growing at a CAGR of 6.30% between 2023 and 2030.
Global healthcare is experiencing a revolutionary shift. From the rise in chronic diseases to the ongoing pandemic, pharmaceutical industries must stay ahead. One critical factor in this progress is the growing oral solid dosage (OSD) contract manufacturing market. With its significant role in medicine production, understanding its current market landscape, projected growth, and key players becomes essential.
Oral Solid Dosage Contract Manufacturing Market current trends are witnessing significant growth and evolution in recent years. With an increasing demand for pharmaceutical products, contract manufacturing has emerged as a popular choice among companies looking to outsource their production processes. One of the key trends in this market is the integration of advanced technologies such as continuous manufacturing, which offers benefits like improved efficiency and reduced costs. Additionally, there is a growing focus on quality control and regulatory compliance, as manufacturers strive to meet stringent industry standards. Another trend entails the rising popularity of specialized dosage forms such as modified-release tablets and chewable tablets, catering to specific patient needs.
Oral Solid Dosage (OSD) forms remain a staple in the pharmaceutical world. They offer diverse delivery systems, including tablets, capsules, powders, and granules. OSDs are highly effective, easy to administer, cost-effective, and stable over time.
These advantages contribute to the burgeoning growth of the OSD contract manufacturing market. Contract manufacturing organizations (CMOs) cater to pharmaceutical companies looking to outsource production, thus enabling them to focus on their core competencies.
OSD Contract Manufacturing: Driving Factors and Market Potential
Several factors are propelling the OSD contract manufacturing market forward. The global increase in chronic diseases demands a robust supply of effective medicines. Moreover, pharmaceutical companies’ need to reduce operational costs and enhance production efficiency is fueling the demand for contract manufacturing.
The industry’s growth is also accelerated by technological advancements. Modern manufacturing facilities employ sophisticated technologies like continuous manufacturing and Quality by Design (QbD) approaches, facilitating faster, more reliable production.
The OSD contract manufacturing market’s potential is enormous. It is expected to witness exponential growth in the next decade. North America and Europe are currently the dominant markets, largely due to their strong pharmaceutical industries and stringent regulations ensuring quality control.
Browse 210 pages report Oral Solid Dosage Contract Manufacturing Market By Type Outlook (Tablets, Capsules, Powders, Granules) By Mechanism Outlook (Immediate-release, Delayed-release, Controlled-release) – Growth, Future Prospects & Competitive Analysis, 2016 – 2030)- https://www.credenceresearch.com/report/oral-solid-dosage-contract-manufacturing-market
Key Players in OSD Contract Manufacturing Market
- Catalent: One of the world’s leading providers of advanced delivery technologies, Catalent offers a comprehensive range of oral solid dosage product development services.
- Patheon, by Thermo Fisher Scientific: Patheon provides unparalleled pharmaceutical product development and commercialization services. Their global network and scientific expertise position them as a leading player in the OSD contract manufacturing market.
- Piramal Pharma Solutions: Piramal offers an end-to-end service range from drug discovery and development to commercialization, including oral solid dosage form manufacturing.
- Lonza: Lonza, a global leader in life sciences, delivers a broad array of services in drug product development, including oral dosage forms.
Embracing a Future with OSD Contract Manufacturing
The growth of the OSD contract manufacturing market brings benefits to pharmaceutical companies, healthcare providers, and patients alike. By partnering with experienced contract manufacturers, pharmaceutical companies can focus on innovative drug discovery and development, leaving the efficient, high-quality manufacturing to the specialists. This efficient model of work division is the future of pharmaceutical production, promising to revolutionize healthcare as we know it.
In conclusion, the OSD contract manufacturing market is experiencing unprecedented growth due to its enormous potential in providing efficient, high-quality drug production. With key players offering sophisticated technologies and services, the future of the pharmaceutical industry is bright and centered around this thriving market.
Why to Buy This Report-
- The report provides a qualitative as well as quantitative analysis of the global Oral Solid Dosage Contract Manufacturing Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.
- The report includes information on the competitive landscape, such as how the market’s top competitors operate at the global, regional, and country levels.
- Major nations in each region with their import/export statistics
- The global Oral Solid Dosage Contract Manufacturing Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.
About Us –
Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.
Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India